Skip to main content
. 2013 Aug 15;11:191. doi: 10.1186/1479-5876-11-191

Table 1.

Characteristics of cancer patients from the clinic database selected for data analysis: number of subjects, sex, age range, weight range, and average ascorbate concentrations before and immediately after the first 15 gram IVC infusion

Cancer type N M/F Age (years) Weight (lbs) Ascorbic acid, post (mM) Ascorbic acid, pre (mM) Ascorbic acid, minimum pre (mM)
Bladder
10
8/2
32–80
160–192
5.00
0.078
0.045
Brain
12
3/9
26–66
126–137
6.73
0.051
0.045
Breast
105
1/133
38–72
104–190
6.57
0.076
0.023
Breast, metastatic
28
0/28
36–64
93–250
5.45
0.060
0.017
Chronic Lymphocytic Leukemia
15
8/7
50–67
125–213
5.52
0.059
0.023
Colon
34
23/11
50–78
110–280
5.46
0.063
0.017
Colon, metastatic
26
16/10
50–69
106–200
6.23
0.062
0.028
Esophagus
5
5/0
48–77
ND
5.99
0.080
0.068
Esophagus, metastatic
5
5/0
50–63
114–280
6.11
0.055
0.011
Liver
8
5/3
14–58
99–157
5.78
0.057
0.034
Liver, metastatic
7
3/4
50–69
85–160
5.90
0.052
0.028
Lung
43
25/18
49–75
104–290
5.81
0.051
0.011
Lung, metastatic
20
10/10
25–78
107–178
5.07
0.060
0.017
lymphoma (non-Hodgkin’s)
6
1/5
40–65
120–159
5.13
0.077
0.063
Melanoma
11
3/8
26–72
130–207
5.26
0.068
0.063
Ovarian
36
0/36
31–76
108–217
6.59
0.058
0.017
Pancreas
16
11/5
58–80
149–200
5.65
0.051
0.028
Pancreas, metastatic
11
7/4
65–80
132–174
5.13
0.068
0.045
Prostate
64
64/0
59–89
147–250
5.61
0.063
0.017
Prostate, metastatic
7
7/0
59–88
150–225
4.64
0.059
0.023
Renal
17
10/7
51–76
72–229
6.08
0.055
0.040
Renal, metastatic
13
7/6
39–68
ND
5.89
0.063
0.040
Sarcoma
7
5/2
21–75
90–163
4.98
0.045
0.023
Skin
6
6/0
54–76
175–211
5.54
0.051
0.028
Stomach
5
4/1
33–77
ND
4.75
0.051
0.028
Throat
7
4/3
34–80
ND
5.40
0.063
0.034
Thymus
7
4/3
48–73
48–73
5.39
0.068
0.051
Uterus 7 0/7 52–70 99–173 6.62 0.068 0.051